Aktis completes $84M funding round
August 26, 2022 -- Aktis Oncology recently completed a series A extension financing round of $84 million, bringing the total capital raised by the company to date to $161 million. Read More
CMS officially postpones changes to radiation therapy payments
August 25, 2022 -- The U.S. Centers for Medicare and Medicaid Services (CMS) has issued a final rule that indefinitely delays the start of an alternative payment model that would have radically changed federal payments for radiation oncology procedures. Read More
NorthStar inks supply deal with Aktis Oncology
August 23, 2022 -- NorthStar Medical Radioisotopes has inked a long-term supply agreement with Aktis Oncology for NorthStar's actinium-225 (Ac-225) therapeutic radioisotope. Read More
Alpha Tau joins forces with MIM Software
August 23, 2022 -- Israeli radiation therapy technology developer Alpha Tau Medical and MIM Software are collaborating to develop new features and support for Alpha Tau's Alpha DaRT treatment across multiple potential indications. Read More
Rocket VR Health and Penn Medicine partner to test headset
August 18, 2022 -- Rocket VR Health and Penn Medicine have partnered to test the company's virtual reality (VR) headset and immersive meditation program in patients undergoing radiation therapy. Read More
Navidea posts revenue declines, net loss increases in Q2
August 15, 2022 -- Radiopharmaceutical developer Navidea Biopharmaceuticals reported a decline in revenues and an increase in net losses for its second quarter and first half of 2022. Read More
Accuray reports Q4, fiscal 2022 revenues
August 11, 2022 -- Accuray reported financial results showing a small dip in revenue in the fourth quarter compared with last year, but an increase in revenue in fiscal year 2022 compared with the previous year. Read More
RANZCR: Workforce challenges face radiation oncology in New Zealand
August 4, 2022 -- A shortage of radiation oncologists may be looming in New Zealand, according to the results of a survey that are being presented at this week's New Zealand Annual Scientific Meeting 2022, hosted by the Royal Australian and New Zealand College of Radiologists (RANZCR). Read More
Radiopharm collaborates with Lantheus on theranostic agent
August 4, 2022 -- Radiopharm Theranostics has entered a collaboration agreement with Lantheus to develop NM-01, a nanobody that can be labeled with radioisotopes to diagnose and treat tumors for theranostic applications. Read More
IBA signs collaboration on proton therapy
August 4, 2022 -- Proton therapy developer Ion Beam Applications (IBA) has signed a collaboration agreement on its ConformalFlash proton therapy technique with the Fred Hutchinson Cancer Center and the University of Washington, both in Seattle. Read More
Special Feature
Representation in radiation oncology remains challenging

Radiation oncology has some of the lowest numbers when it comes to female senior faculty representation, according to research published in JAMA Network Open. Read more